[The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
D000818:Animals; D001381:Azepines / Q000494:pharmacology* / Q000633:toxicity; D001565:Benzoates / Q000494:pharmacology / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D004077:Digoxin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D004285:Dogs; D004338:Drug Combinations; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000633:toxicity
D001381:Azepines; D001565:Benzoates; D004338:Drug Combinations; D014665:Vasodilator Agents; D004077:Digoxin
Zur Pharmakologie des Kombinationspräparates Dilazep/beta-Acetyldigoxin